, Tracking Stock Market Picks
Enter Symbol:
Salix Pharmaceuticals, Ltd. (SLXP) [hlAlert]

up 330.60 %

Salix Pharmaceuticals, Ltd. (SLXP) rated Overweight with price target $52 by Thomas Weisel

Posted on: Wednesday,  Apr 14, 2010  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) on 04/14/2010, when the stock price was $39.34. Since
then, Salix Pharmaceuticals, Ltd. has gained 330.60% as of 03/31/2015's recent price of $169.40.
If you would have followed this Thomas Weisel's recommendation on SLXP, you would have gained 330.6% of your investment in 1812 days.

Salix Pharmaceuticals, Ltd. objective is to be a market-driven specialtypharmaceutical company focussed on the needs of physicians specializing ingastroenterology. The company intends to establish a small direct sales force to promote its products to this specialist audience. The company's strategy is to identify and acquire products that have near-term commercial potential and apply its regulatory and product development expertise to commercialize these products. The company selects products that it believes serve a gastrointestinal disease.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/14/2010 8:25 AM Buy
39.34 52.00
as of 12/31/2010
1 Week down  -14.22 %
1 Month down  -8.86 %
3 Months up  2.44 %
1 YTD up  3.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy